Javascript must be enabled to continue!
Phytochemicals in Cancer Therapy: Unleashing the Healing Power of Herbs
View through CrossRef
Introduction:
Cancer is a complex disease caused by genetic mutations and external factors
like radiation and lifestyle choices. Traditional treatments, including chemotherapy and radiation,
often cause severe side effects, prompting interest in alternative therapies. Herbal remedies, rich in
phytochemicals, have shown promise in cancer prevention and treatment by targeting tumor growth,
inducing apoptosis, and inhibiting angiogenesis and metastasis.
Objective:
This review article aims to explore and analyze the potential of herbal remedies in cancer
treatment, focusing on their mechanisms of action, including apoptosis induction, inhibition of angiogenesis,
and modulation of molecular pathways.
Methods:
This review examines key phytochemicals curcumin, naringenin, capsaicin, and resveratrol
for their anticancer properties. Relevant studies were analyzed to assess their mechanisms of action,
such as apoptosis induction, inhibition of molecular pathways like COX-2 and 5-LOX, and protective
effects on healthy cells. A literature search was conducted using databases such as PubMed, Scopus,
and Web of Science. Keywords included “phytochemicals,” “herbal,” “curcumin,” “naringenin,”
“capsaicin,” “resveratrol,” “herbal remedies,” and “cancer therapy.” Studies published in peerreviewed
journals over the past 30 years were selected. The quality of the literature was assessed
based on study design, sample size, reproducibility, and relevance to cancer treatment.
Results:
The findings highlight that these phytochemicals exert significant anti-cancer effects by inducing
cell cycle arrest and apoptosis while inhibiting angiogenesis and metastasis. For example, curcumin
and resveratrol inhibit cancer progression by targeting key molecular pathways. Additionally,
herbal remedies protect healthy cells from damage often caused by chemotherapy and radiation, making
them an attractive alternative or complementary option for treatment.
Discussion:
These phytochemicals demonstrated significant therapeutic potential through multitargeted
actions, such as apoptosis induction, angiogenesis inhibition, and protection of healthy cells.
Their ability to complement conventional therapies, highlights the relevance of integrating herbal
remedies into cancer management strategies.
Conclusion::
Herbal remedies, with their potent phytochemicals, offer a promising alternative to cancer
therapy, providing protective effects to normal cells while targeting cancerous ones. Their lower
toxicity compared to conventional treatments suggests they could play a crucial role in future cancer
therapies. However, further clinical research is needed to establish optimal dosages and treatment
protocols for effective integration into cancer care.
Bentham Science Publishers Ltd.
Title: Phytochemicals in Cancer Therapy: Unleashing the Healing Power of Herbs
Description:
Introduction:
Cancer is a complex disease caused by genetic mutations and external factors
like radiation and lifestyle choices.
Traditional treatments, including chemotherapy and radiation,
often cause severe side effects, prompting interest in alternative therapies.
Herbal remedies, rich in
phytochemicals, have shown promise in cancer prevention and treatment by targeting tumor growth,
inducing apoptosis, and inhibiting angiogenesis and metastasis.
Objective:
This review article aims to explore and analyze the potential of herbal remedies in cancer
treatment, focusing on their mechanisms of action, including apoptosis induction, inhibition of angiogenesis,
and modulation of molecular pathways.
Methods:
This review examines key phytochemicals curcumin, naringenin, capsaicin, and resveratrol
for their anticancer properties.
Relevant studies were analyzed to assess their mechanisms of action,
such as apoptosis induction, inhibition of molecular pathways like COX-2 and 5-LOX, and protective
effects on healthy cells.
A literature search was conducted using databases such as PubMed, Scopus,
and Web of Science.
Keywords included “phytochemicals,” “herbal,” “curcumin,” “naringenin,”
“capsaicin,” “resveratrol,” “herbal remedies,” and “cancer therapy.
” Studies published in peerreviewed
journals over the past 30 years were selected.
The quality of the literature was assessed
based on study design, sample size, reproducibility, and relevance to cancer treatment.
Results:
The findings highlight that these phytochemicals exert significant anti-cancer effects by inducing
cell cycle arrest and apoptosis while inhibiting angiogenesis and metastasis.
For example, curcumin
and resveratrol inhibit cancer progression by targeting key molecular pathways.
Additionally,
herbal remedies protect healthy cells from damage often caused by chemotherapy and radiation, making
them an attractive alternative or complementary option for treatment.
Discussion:
These phytochemicals demonstrated significant therapeutic potential through multitargeted
actions, such as apoptosis induction, angiogenesis inhibition, and protection of healthy cells.
Their ability to complement conventional therapies, highlights the relevance of integrating herbal
remedies into cancer management strategies.
Conclusion::
Herbal remedies, with their potent phytochemicals, offer a promising alternative to cancer
therapy, providing protective effects to normal cells while targeting cancerous ones.
Their lower
toxicity compared to conventional treatments suggests they could play a crucial role in future cancer
therapies.
However, further clinical research is needed to establish optimal dosages and treatment
protocols for effective integration into cancer care.
Related Results
Alternative use of herbs in modern pharmacology based on ancient sources
Alternative use of herbs in modern pharmacology based on ancient sources
The use of medicinal herbs for treatment of illnesses is as old as humanity. Herbs have a long history, which is lost through the ages. Herbs are plants that are used in cooking as...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract
Introduction
Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...
International Breast Cancer Study Group (IBCSG)
International Breast Cancer Study Group (IBCSG)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by International Breast Cancer Study Group (IBCSG). Clinical tria...
Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
Purpose:
To make a diagnosis of cancer with BDORT (resonance test), we can choose two methods. One is to use a chemical agent like Integrin α5β1 or Oncogene C-f...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Performance of Self-Healing Cementitious Composites Using Aligned Tubular Healing Fiber
Performance of Self-Healing Cementitious Composites Using Aligned Tubular Healing Fiber
From the perspective of improving the self-healing method in construction, a tubular healing fiber was adopted as a container to improve the encapsulation capacity, which was avail...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...

